Don't get sucked in by pie in the sky.
New technologies sound exciting - the early companies usually fall by the wayside.
TRXC is at a $50M annual burn rate. A dilutive offering has already been filed.
The market cap is $200M.
Medical device companies sell for 20X earnings.
So IF sometime in the future, they get a product approved and produce $10M of earnings,
you'll be able to buy the stock at half the current price because there will be twice as many shares
I would wait this one out.
A speculative stock to consider now is GTHP.
The international markets are much larger.
Why even piddle around in the US now?
Focus on Africa, Asia, South America, Canada....
Become profitable and then pursue the US market.
We're in break out mode.
Don't get suckered by this morning's dip, we'll be off to the races this afternoon.
I agree, If the FDA asked for another trial, Gene would be required to disclose it this morning.
I smell APPROVAL!
An excellent time to load up.
This is a great time to reload. It corrected off today's run and is now ready to head higher again.